InvestorsHub Logo

vg_future

02/04/22 5:26 PM

#349286 RE: RedShoulder #349283

Thanks RedShoulder. Please post the second part of the conversation...with more meat. I don't want to steal the flow from you....I really liked part of the last bit in there.."concrete plan laid out for the company"

-vg_future

nidan7500

02/04/22 5:35 PM

#349287 RE: RedShoulder #349283

Great effort REDShoulder. Thank you.

IMO, there is more to the AVXL S1R MOA story (in a positive way) than can be said out loud right now. FDA are a lot of things but being politically deaf-blind ain't one of them. IMO, the FDA see the A2-73 PDD follow up (extended use positive potential-OLE) and the RSD results as a much bigger envelope w/potential political ++ all over it. They cannot screw that one up. Being critical of AVXL right now is not in their best interest. IMO. This is yuge. Waiting for a while is just being smart...quiet is a part of that strategy...only the shorts/thieves benefit from our continuous public trivial RSD blanket party.

AVXL is a massive CNS winner. W/S and FUD masters have PIXXED off the wrong people. IMO. We'll see.

Jager997

02/04/22 7:26 PM

#349306 RE: RedShoulder #349283

Red, re-post your second section of IR discussion. Leave out the cuss word.

rayovacAAA

02/05/22 12:00 PM

#349426 RE: RedShoulder #349283

WHO IS "ALEXRENARD07 ON ST" AND WHAT MAKES THEM A RELIABLE SOURCE OF INFORMATION ON AVXL??????

ok so just got off the phone with IR. I'm paraphrasing what we both said:
Q: Why do the slides from the JP Morgan conference list it as a phase 2/3 and only RSBQ if it had already been changed to a Phase 3 and to RSBQ-AUC?
A: Phase 2/3 and RSBQ were what was publically known so the company could not present alternate information without releasing it publically before hand.
Q: Then why didn't you do that?
A: There are certain things we wish we had done differently? The changes were made at the request of the FDA.
Q: You are confirming that the FDA directly requested that Anavex change the trial to a Phase 3 and that the endpoints be changed?
A: Yes I can confirm that.
Q: Why on the conference call did Missling talk solely about the FDA guidance and nothing about the UK or Australia, and then on today's press release it was the exact opposite?

From alexrenard07 on ST.




WE GOT THIS!!!!!!